DT
Douglas Tsao HC Wainwright & Co Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
77
Avg Return
Past Year
Past Year
16%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
80%
Neutral
20%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Diagnostics & Research
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Neutral
Maintained
| $7 |
2%
upside
| 1 | – |
–
| 12 Mar ‘26 1 month ago |
|
|
|
Buy
Maintained
| $74 |
30%
upside
| 1 | +31% |
0
%
| 10 Mar ‘26 1 month ago |
|
|
|
Neutral
Maintained
| $10 |
8%
downside
| 2 | -34% |
0
%
| 4 Mar ‘26 1 month ago |
|
|
|
Buy
Maintained
| $15 |
10%
downside
| 2 | -0.78% |
0
%
| 4 Mar ‘26 1 month ago |
|
|
|
Buy
Maintained
| $34 |
17%
upside
| 2 | +17% |
0
%
| 4 Mar ‘26 1 month ago |
|
|
|
Buy
Maintained
| $940 |
13%
upside
| 1 | +3.8% |
0
%
| 27 Feb ‘26 1 month ago |
|
|
|
Buy
Maintained
| $34 |
39%
upside
| 1 | +24% |
0
%
| 26 Feb ‘26 1 month ago |
|
|
|
Buy
Maintained
| $48 |
17%
upside
| 1 | -3.8% |
0
%
| 25 Feb ‘26 1 month ago |
|
|
|
Neutral
Reiterated
| $0.5000 |
35%
upside
| 2 | -42% |
–
| 18 Feb ‘26 2 months ago |
|
|
|
Buy
Reiterated
| $35 |
23%
upside
| 1 | +15% |
0
%
| 10 Feb ‘26 2 months ago |
|
|
|
Buy
Maintained
| $13 |
156%
upside
| 2 | -15% |
0
%
| 3 Feb ‘26 2 months ago |
|
|
|
Buy
Maintained
| $1,245 |
263%
upside
| 1 | +37% |
0
%
| 30 Jan ‘26 2 months ago |
|
|
|
Buy
Maintained
| $117 |
11%
upside
| 1 | +15% |
0
%
| 30 Jan ‘26 2 months ago |
|